Peter P. Pfreundschuh, Chief Financial Officer at Voyager Therapeutics, Inc. (VYGR), sold 27,134 shares at $6.99 ($190K) on 2023-10-03, disclosed to the SEC on 2023-10-05.
Open-market sale of $190k VYGR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.99 | 13,567 | $95K | 50.0% |
| 2 | $6.99 | 13,567 | $95K | 50.0% |
| Total | $6.99 avg | 27,134 | $190K | 100% |
| Filing → |
| FREQ | SELL | 2022-02-18 | $11K | — | Filing → |
| FREQ | SELL | 2022-02-16 | $6K | — | Filing → |
| URGN | SELL | 2020-10-16 | $52K | — | Filing → |